Compile Data Set for Download or QSAR
Report error Found 214 Enz. Inhib. hit(s) with all data for entry = 12434
TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702472BDBM702472(US20240360148, Example 225)
Affinity DataIC50: 34nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702470BDBM702470(US20240360148, Example 223)
Affinity DataIC50: 52nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702467BDBM702467(US20240360148, Example 220)
Affinity DataIC50: 67nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702395BDBM702395(US20240360148, Example 139)
Affinity DataIC50: 70nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702469BDBM702469(US20240360148, Example 222)
Affinity DataIC50: 100nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702498BDBM702498(US20240360148, Example 251)
Affinity DataIC50: 110nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702396BDBM702396(US20240360148, Example 140)
Affinity DataIC50: 120nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702474BDBM702474(US20240360148, Example 227)
Affinity DataIC50: 120nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702383BDBM702383(US20240360148, Example 122)
Affinity DataIC50: 120nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702464BDBM702464(US20240360148, Example 217)
Affinity DataIC50: 130nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702496BDBM702496(US20240360148, Example 249)
Affinity DataIC50: 140nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702304BDBM702304(US20240360148, Example 21)
Affinity DataIC50: 150nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702478BDBM702478(US20240360148, Example 231)
Affinity DataIC50: 160nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702471BDBM702471(US20240360148, Example 224)
Affinity DataIC50: 172nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702389BDBM702389(US20240360148, Example 132)
Affinity DataIC50: 180nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702403BDBM702403(US20240360148, Example 151)
Affinity DataIC50: 180nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702463BDBM702463(US20240360148, Example 216)
Affinity DataIC50: 180nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702320BDBM702320(US20240360148, Example 46)
Affinity DataIC50: 200nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702287BDBM702287(US20240360148, Example 1)
Affinity DataIC50: 210nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702483BDBM702483(US20240360148, Example 236)
Affinity DataIC50: 240nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702379BDBM702379(US20240360148, Example 118)
Affinity DataIC50: 290nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702381BDBM702381(US20240360148, Example 120)
Affinity DataIC50: 310nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702390BDBM702390(US20240360148, Example 134)
Affinity DataIC50: 320nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702327BDBM702327(US20240360148, Example 53)
Affinity DataIC50: 340nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702468BDBM702468(US20240360148, Example 221)
Affinity DataIC50: 347nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702397BDBM702397(US20240360148, Example 141)
Affinity DataIC50: 350nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702393BDBM702393(US20240360148, Example 137)
Affinity DataIC50: 360nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702499BDBM702499(US20240360148, Example 252)
Affinity DataIC50: 390nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702305BDBM702305(US20240360148, Example 22)
Affinity DataIC50: 390nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702354BDBM702354(US20240360148, Example 92)
Affinity DataIC50: 400nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702382BDBM702382(US20240360148, Example 121)
Affinity DataIC50: 430nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702380BDBM702380(US20240360148, Example 119)
Affinity DataIC50: 440nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702394BDBM702394(US20240360148, Example 138)
Affinity DataIC50: 500nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702388BDBM702388(US20240360148, Example 129)
Affinity DataIC50: 505nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702391BDBM702391(US20240360148, Example 135)
Affinity DataIC50: 510nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702324BDBM702324(US20240360148, Example 50)
Affinity DataIC50: 510nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702399BDBM702399(US20240360148, Example 144)
Affinity DataIC50: 540nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702328BDBM702328(US20240360148, Example 54)
Affinity DataIC50: 550nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702402BDBM702402(US20240360148, Example 147)
Affinity DataIC50: 620nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702326BDBM702326(US20240360148, Example 52)
Affinity DataIC50: 690nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702303BDBM702303(US20240360148, Example 20)
Affinity DataIC50: 690nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702387BDBM702387(US20240360148, Example 128)
Affinity DataIC50: 750nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702345BDBM702345(US20240360148, Example 83)
Affinity DataIC50: 760nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702373BDBM702373(US20240360148, Example 112)
Affinity DataIC50: 760nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702355BDBM702355(US20240360148, Example 93)
Affinity DataIC50: 760nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702497BDBM702497(US20240360148, Example 250)
Affinity DataIC50: 760nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702368BDBM702368(US20240360148, Example 106)
Affinity DataIC50: 800nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702487BDBM702487(US20240360148, Example 240)
Affinity DataIC50: 810nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702465BDBM702465(US20240360148, Example 218)
Affinity DataIC50: 810nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetSUMO-activating enzyme subunit 1(Human)
Suvalent Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 702495BDBM702495(US20240360148, Example 248)
Affinity DataIC50: 970nMAssay Description:Assay buffer was prepared [50 mM HEPES, pH 7.5, 0.1% BSA and 10 mM MgCl2] as was the Stop Buffer [100 mM HEPES, pH 7.5, 0.05% Tween20, and 410 mM KF]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

Displayed 1 to 50 (of 214 total ) | Next | Last >>
Jump to: